Author

J. Bragazzi Cunha

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. C. Ferguson· 1 shared B. Omary· 1 shared B. T. Emmer· 1 shared C. E. Wobus· 1 shared C. Mirabelli· 1 shared D. Maitra· 1 shared E. J. Sherman· 1 shared J. A. Shavit· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. C. Ferguson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJun 9, 2022

ARF6 is a host factor for SARS-CoV-2 infection in vitro

C. Mirabelli, E. J. Sherman, J. Bragazzi Cunha…·C. E. Wobus

This study identifies ARF6 as a host factor critical for SARS-CoV-2 entry and infection in vitro, showing its importance across different cell models.

DOI 10.1101/2022.06.09.495482

humangenetic perturbation / CRISPR

𝕏 PostBluesky

PathologybioRxivMar 30, 2021

Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models

J. Bragazzi Cunha, J. S. Elenbaas, D. Maitra…·B. Omary

This study identifies acitretin as a potential treatment for congenital erythropoietic porphyria by mitigating uroporphyrin-induced bone defects in a zebrafish model.

DOI 10.1038/s41598-021-88668-9

zebrafishexperimental assay

𝕏 PostBluesky